LESINURAD, A NOVEL SELECTIVE URIC ACID REABSORPTION INHIBITOR, IN COMBINATION WITH FEBUXOSTAT, IN PATIENTS WITH TOPHACEOUS GOUT: THE CRYSTAL PHASE III CLINICAL TRIAL

被引:12
作者
Dalbeth, N. [1 ]
Jones, G. [2 ]
Terkeltaub, R. [3 ]
Khanna, D. [4 ]
Kopicko, J. [5 ]
Bhakta, N. [5 ]
Fung, M. [5 ]
Storgard, C. [5 ]
Baumgartner, S. [5 ]
Perez-Ruiz, F. [6 ]
机构
[1] Univ Auckland, Auckland, New Zealand
[2] Univ Tasmania, Hobart, Tas, Australia
[3] Univ Calif San Diego, San Diego, CA 92103 USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Ardea Biosci Inc, San Diego, CA USA
[6] Hosp Univ Cruces, Baracaldo, Spain
关键词
D O I
10.1136/annrheumdis-2015-eular.2182
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
SAT0329
引用
收藏
页码:778 / 778
页数:1
相关论文
empty
未找到相关数据